The Burden of Carbapenem-Resistant

Acinetobacter baumannii Acinetobacter infections COVID-19 SARS-CoV-2 antimicrobial drug resistance carbapenems critical care intensive care unit multidrug resistance nosocomial infections

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
02 Sep 2022
Historique:
received: 11 07 2022
revised: 26 08 2022
accepted: 26 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 10 9 2022
Statut: epublish

Résumé

Since the beginning of the COVID-19 pandemic, the impact of superinfections in intensive care units (ICUs) has progressively increased, especially carbapenem-resistant Acinetobacter baumannii (CR-Ab). This observational, multicenter, retrospective study was designed to investigate the characteristics of COVID-19 ICU patients developing CR-Ab colonization/infection during an ICU stay and evaluate mortality risk factors in a regional ICU network. A total of 913 COVID-19 patients were admitted to the participating ICUs; 19% became positive for CR-Ab, either colonization or infection (n = 176). The ICU mortality rate in CR-Ab patients was 64.7%. On average, patients developed colonization or infection within 10 ± 8.4 days from ICU admission. Scores of SAPS II and SOFA were significantly higher in the deceased patients (43.8 ± 13.5, p = 0.006 and 9.5 ± 3.6, p < 0.001, respectively). The mortality rate was significantly higher in patients with extracorporeal membrane oxygenation (12; 7%, p = 0.03), septic shock (61; 35%, p < 0.001), and in elders (66 ± 10, p < 0.001). Among the 176 patients, 129 (73%) had invasive infection with CR-Ab: 105 (60.7%) Ventilator-Associated Pneumonia (VAP), and 46 (26.6%) Bloodstream Infections (BSIs). In 22 cases (6.5%), VAP was associated with concomitant BSI. Colonization was reported in 165 patients (93.7%). Mortality was significantly higher in patients with VAP (p = 0.009). Colonized patients who did not develop invasive infections had a higher survival rate (p < 0.001). Being colonized by CR-Ab was associated with a higher risk of developing invasive infections (p < 0.001). In a multivariate analysis, risk factors significantly associated with mortality were age (OR = 1.070; 95% CI (1.028−1.115) p = 0.001) and CR-Ab colonization (OR = 5.463 IC95% 1.572−18.988, p = 0.008). Constant infection-control measures are necessary to stop the spread of A. baumannii in the hospital environment, especially at this time of the SARS-CoV-2 pandemic, with active surveillance cultures and the efficient performance of a multidisciplinary team.

Identifiants

pubmed: 36079137
pii: jcm11175208
doi: 10.3390/jcm11175208
pmc: PMC9456723
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Infect Dis. 2021 May 18;72(10):e533-e541
pubmed: 32820807
J Clin Microbiol. 2016 Mar;54(3):593-612
pubmed: 26699703
J Glob Antimicrob Resist. 2021 Mar;24:136-147
pubmed: 32889142
J Clin Microbiol. 1998 Jul;36(7):1938-41
pubmed: 9650940
Crit Care Med. 2014 May;42(5):1081-8
pubmed: 24394630
Med Intensiva. 2017 Nov;41(8):497-499
pubmed: 28081920
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):1999-2006
pubmed: 27287765
Virulence. 2012 May 1;3(3):243-50
pubmed: 22546906
Crit Care. 2021 Aug 31;25(1):317
pubmed: 34461962
J Infect Dev Ctries. 2021 Jan 31;15(1):58-68
pubmed: 33571146
J Infect. 2019 Aug;79(2):130-138
pubmed: 31145911
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502
pubmed: 33389263
J Med Microbiol. 2020 Jul;69(7):949-959
pubmed: 32584215
Infect Control Hosp Epidemiol. 2022 Jun;43(6):815-817
pubmed: 33685542
Infect Control Hosp Epidemiol. 2022 Apr;43(4):461-466
pubmed: 33858547
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Membranes (Basel). 2021 Apr 30;11(5):
pubmed: 33946566
PLoS One. 2021 Mar 25;16(3):e0249038
pubmed: 33765049
Intensive Care Med. 2015 Dec;41(12):2057-75
pubmed: 26438224
Intensive Care Med. 2018 Dec;44(12):2216-2218
pubmed: 29797028
J Med Virol. 2021 Jul;93(7):4564-4569
pubmed: 33822390
BMC Infect Dis. 2018 Jan 5;18(1):11
pubmed: 29304746
Clin Microbiol Infect. 2020 Jul;26(7):808-810
pubmed: 32360446
Clin Microbiol Infect. 2021 Mar;27(3):451-457
pubmed: 33223114
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):797-805
pubmed: 28000030
J Glob Antimicrob Resist. 2020 Dec;23:398-400
pubmed: 33242674
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Curr Opin Infect Dis. 2019 Feb;32(1):69-76
pubmed: 30520737
Pathogens. 2021 Aug 10;10(8):
pubmed: 34451470
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Infect Prev Pract. 2021 Mar;3(1):100113
pubmed: 34316574
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Crit Care Med. 2013 Dec;41(12):2733-42
pubmed: 23982021
Crit Care Med. 2011 Apr;39(4):651-8
pubmed: 21242793
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Membranes (Basel). 2021 Aug 09;11(8):
pubmed: 34436366
Microb Drug Resist. 2021 Sep;27(9):1167-1175
pubmed: 33600262
BMC Infect Dis. 2020 Sep 1;20(1):646
pubmed: 32873235
Ann Intensive Care. 2021 Sep 15;11(1):136
pubmed: 34524562
J Clin Med. 2021 Feb 03;10(4):
pubmed: 33546093
Antimicrob Resist Infect Control. 2021 Aug 19;10(1):123
pubmed: 34412693

Auteurs

Giorgia Montrucchio (G)

Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
Department of Anaesthesia, Critical Care and Emergency-Città Della Salute e Della Scienza Hospital, Corso Dogliotti 14, 10126 Turin, Italy.

Silvia Corcione (S)

Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.
Division of Geographic Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.

Tommaso Lupia (T)

Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.

Nour Shbaklo (N)

Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.

Carlo Olivieri (C)

S.C. Anestesia e Rianimazione, Ospedale Sant'Andrea, 13100 Vercelli, Italy.

Miriam Poggioli (M)

S.C. Anestesia e Rianimazione, Ospedale Sant'Andrea, 13100 Vercelli, Italy.

Aline Pagni (A)

S.C. Anestesia e Rianimazione, Ospedale SS. Trinità-Borgomanero-ASL NO, 28021 Borgomanero, Italy.

Davide Colombo (D)

S.C. Anestesia e Rianimazione, Ospedale SS. Trinità-Borgomanero-ASL NO, 28021 Borgomanero, Italy.

Agostino Roasio (A)

S.C. Anestesia e Rianimazione, Ospedale Cardinal Massaia, 14100 Asti, Italy.

Stefano Bosso (S)

S.C. Anestesia e Rianimazione, Ospedale Cardinal Massaia, 14100 Asti, Italy.

Fabrizio Racca (F)

S.C. Anestesia e Rianimazione, Ospedale SS. Arrigo e Biagio, 15121 Alessandria, Italy.

Valeria Bonato (V)

S.C. Anestesia e Rianimazione, Ospedale SS. Arrigo e Biagio, 15121 Alessandria, Italy.

Francesco Della Corte (F)

Department of Translational Medicine, Maggiore della Carità Hospital, University of Eastern Piedmont-UPO, 28100 Novara, Italy.

Stefania Guido (S)

Department of Translational Medicine, Maggiore della Carità Hospital, University of Eastern Piedmont-UPO, 28100 Novara, Italy.

Andrea Della Selva (A)

S.C. Anestesia e Rianimazione, ASL CN2, 12060 Verduno, Italy.

Enrico Ravera (E)

S.C. Anestesia e Rianimazione, ASL CN2, 12060 Verduno, Italy.

Nicoletta Barzaghi (N)

Dipartimento di Emergenza ed Aree Critiche, SSD Rianimazione, A.S.O.S. Croce e Carle, 12100 Cuneo, Italy.

Martina Cerrano (M)

Dipartimento di Emergenza ed Aree Critiche, SSD Rianimazione, A.S.O.S. Croce e Carle, 12100 Cuneo, Italy.

Pietro Caironi (P)

S.C.DU Anestesia e Rianimazione, AOU S. Luigi Gonzaga, Dipartimento di Oncologia, Università degli Studi di Torino, 10043 Orbassano, Italy.

Giacomo Berta (G)

S.C.DU Anestesia e Rianimazione, AOU S. Luigi Gonzaga, Dipartimento di Oncologia, Università degli Studi di Torino, 10043 Orbassano, Italy.

Cecilia Casalini (C)

S.C. Anestesia e Rianimazione, Ospedale di Ivrea, ASL TO4, 10015 Ivrea, Italy.

Bruno Scapino (B)

S.C. Anestesia e Rianimazione, Ospedale di Ivrea, ASL TO4, 10015 Ivrea, Italy.

Michele Grio (M)

S.C. Anestesia e Rianimazione, Ospedale di Rivoli, 10098 Rivoli, Italy.

Massimiliano Parlanti Garbero (M)

S.C. Anestesia e Rianimazione, Ospedale di Rivoli, 10098 Rivoli, Italy.

Gabriella Buono (G)

S.C. Rianimazione Generale, AO Ordine Mauriziano, 10128 Turin, Italy.

Federico Finessi (F)

S.C. Rianimazione Generale, AO Ordine Mauriziano, 10128 Turin, Italy.

Simona Erbetta (S)

S.C. Anestesia e Rianimazione Moncalieri-Carmagnola, ASL TO5, 10023 Chieri, Italy.

Paola Federica Sciacca (PF)

S.C. Anestesia e Rianimazione Moncalieri-Carmagnola, ASL TO5, 10023 Chieri, Italy.

Gilberto Fiore (G)

S.C. Anestesia e Rianimazione Moncalieri-Carmagnola, ASL TO5, 10023 Chieri, Italy.

Alessandro Cerutti (A)

S.C. Anestesia e Rianimazione Moncalieri-Carmagnola, ASL TO5, 10023 Chieri, Italy.

Sergio Livigni (S)

S.C Anestesia e Rianimazione Ospedale S. Giovanni Bosco, ASL Città di Torino, 10144 Turin, Italy.

Daniela Silengo (D)

S.C Anestesia e Rianimazione Ospedale S. Giovanni Bosco, ASL Città di Torino, 10144 Turin, Italy.

Fulvio Agostini (F)

S.C. Anestesia e Rianimazione, Presidio CTO, AOU Città della Salute e della Scienza, 10126 Turin, Italy.

Maurizio Berardino (M)

S.C. Anestesia e Rianimazione, Presidio CTO, AOU Città della Salute e della Scienza, 10126 Turin, Italy.

Mauro Navarra (M)

S.C. Anestesia e Rianimazione, Ospedale Martini, ASL Città di Torino, 10149 Turin, Italy.

Silvia Vendramin (S)

S.C. Anestesia e Rianimazione, Ospedale Martini, ASL Città di Torino, 10149 Turin, Italy.

Enzo Castenetto (E)

S.C. Anestesia e Rianimazione, Ospedale di Chivasso, ASL TO4, 10034 Chivasso, Italy.

Marco Maria Liccardi (MM)

S.C. Anestesia e Rianimazione, Ospedale di Chivasso, ASL TO4, 10034 Chivasso, Italy.

Emilpaolo Manno (E)

S.C. Anestesia e Rianimazione, Ospedale Maria Vittoria, ASL Città di Torino, 10144 Turin, Italy.

Luca Brazzi (L)

Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
Department of Anaesthesia, Critical Care and Emergency-Città Della Salute e Della Scienza Hospital, Corso Dogliotti 14, 10126 Turin, Italy.

Francesco Giuseppe De Rosa (FG)

Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.

Classifications MeSH